Stabilization, characterization, and selective removal of cystatin C amyloid oligomers

Journal of Biological Chemistry

Volumn 288, Issue 23, 2013, Pages 16438-16450

  Östner, Gustav ^a   Lindström, Veronica ^a   Christensen, Per Hjort ^b   Kozak, Maciej ^c   Abrahamson, Magnus ^a   Grubb, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b AGILENT TECHNOLOGIES   (United States)

^c ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FLUIDS; DYNAMIC EQUILIBRIA; HIGH MOLECULAR WEIGHT; INTRAMOLECULAR DISULFIDE BONDS; MONOMERIC PROTEINS; PATHOPHYSIOLOGICAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; STRUCTURE AND PROPERTIES;

ANTIBODIES; ATOMIC FORCE MICROSCOPY; COVALENT BONDS; ELECTROPHORESIS; GLYCOPROTEINS; MASS SPECTROMETRY;

DIMERS;

AMYLOID PROTEIN; CYSTATIN C; DIMER; MONOMER; OLIGOMER; PROTEINASE; TETRAMER;

ANTIBODY ISOLATION; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DISULFIDE BOND; ENZYME INHIBITION; GEL FILTRATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; OXIDATION REDUCTION STATE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN STABILITY;

AMYLOID; CYSTATIN C; DOMAIN SWAPPING; PROTEASE INHIBITOR; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DOMAINS; PROTEIN MISFOLDING;

ADULT; AMYLOID; AMYLOIDOSIS; ANIMALS; ANTIBODIES; CYSTATIN C; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, QUATERNARY; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 84878769258     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.469593     Document Type: Article

References (44)

1. Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S., Merlini, G., Saraiva, M. J., and Westermark, P. (2010) Amyloid fibril protein nomenclature. 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17, 101-104
2. Chiti, F., and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366 (Pubitemid 44118036)
3. Glabe, C. G. (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 27, 570-575
4. Bemporad, F., and Chiti, F. (2012) Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem. Biol. 19, 315-327
5. 2- Microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages. Nat. Struct. Mol. Biol. 18, 49-55
6. Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., Cascio, D., Glabe, C., and Eisenberg, D. (2012) Atomic view of a toxic amyloid small oligomer. Science 335, 1228-1231
7. Nilsson, M., Wang, X., Rodziewicz-Motowidlo, S., Janowski, R., Lindström, V., Onnerfjord, P., Westermark, G., Grzonka, Z., Jaskolski, M., and Grubb, A. (2004) Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J. Biol. Chem. 279, 24236-24245 (Pubitemid 38725285)
8. Abrahamson, M., Dalbøge, H., Olafsson, I., Carlsen, S., and Grubb, A. (1988) Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett. 236, 14-18
9. Gerhartz, B., Ekiel, I., and Abrahamson, M. (1998) Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry 37, 17309-17317 (Pubitemid 29013789)
10. Chen, J. M., Dando, P. M., Rawlings, N. D., Brown, M. A., Young, N. E., Stevens, R. A., Hewitt, E., Watts, C., and Barrett, A. J. (1997) Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272, 8090-8098 (Pubitemid 27137377)
11. Yamane, T., Takeuchi, K., Yamamoto, Y., Li, Y. H., Fujiwara, M., Nishi, K., Takahashi, S., and Ohkubo, I. (2002) Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein. Biochim. Biophys. Acta 1596, 108-120 (Pubitemid 34450844)
12. Lindahl, P., Abrahamson, M., and Björk, I. (1992) Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem. J. 281, 49-55
13. Fasman, G. D. (1989) Practical Handbook of Biochemistry and Molecular Biology, CRC Press, Boca Raton, FL
14. Kyhse-Andersen, J., Schmidt, C., Nordin, G., Andersson, B., Nilsson-Ehle, P., Lindström, V., and Grubb, A. (1994) Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem. 40, 1921-1926
15. Olafsson, I., Löfberg, H., Abrahamson, M., and Grubb, A. (1988) Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand. J. Clin. Lab. Invest. 48, 573-582
16. Östner, G., Lindström, V., Postnikov, A. B., Solovyeva, T. I., Emilsson, Ö. I., and Grubb, A. (2011) High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy. Scand. J. Clin. Lab. Invest. 71, 676-682
17. Abrahamson, M., and Grubb, A. (1994) Increased body temperature accelerates aggregation of the Leu-68→Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc. Natl. Acad. Sci. U.S.A. 91, 1416-1420 (Pubitemid 24059022)
18. Rasband, W. S. (1997-2011) ImageJ. 1.43 Ed., U. S. National Institutes of Health, Bethesda, MD
19. Klapetek, P., Necas, D., Campbellova, A., Yacoot, A., and Koenders, L. (2011) Methods for determining and processing 3D errors and uncertainties for AFM data analysis. Meas. Sci. Technol. 22, 25501-25510
20. Alvarez-Fernandez, M., Barrett, A. J., Gerhartz, B., Dando, P. M., Ni, J., and Abrahamson, M. (1999) Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274, 19195-19203
21. Wahlbom, M., Wang, X., Lindström, V., Carlemalm, E., Jaskolski, M., and Grubb, A. (2007) Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J. Biol. Chem. 282, 18318-18326 (Pubitemid 47100211)
22. Nilsson, L. Å. (1983) Double diffusion-in-gel. Scand. J. Immunol. 17, 57-68
23. Jeppson, J. O., Laurell, C. B., and Franzén, B. (1979) Agarose gel electrophoresis. Clin. Chem. 25, 629-638 (Pubitemid 9167007)
24. Janowski, R., Kozak, M., Janowska, E., Grzonka, Z., Grubb, A., Abrahamson, M., and Jaskolski, M. (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8, 316-320 (Pubitemid 32275015)
25. Kolodziejczyk, R., Michalska, K., Hernandez-Santoyo, A., Wahlbom, M., Grubb, A., and Jaskolski, M. (2010) Crystal structure of human cystatin C stabilized against amyloid formation. FEBS J. 277, 1726-1737
26. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., and Turk, V. (1988) The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7, 2593-2599
27. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (Pubitemid 36444329)
28. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191 (Pubitemid 46825511)
29. Citron, M. (2010) Alzheimer's disease. Strategies for disease modification. Nat. Rev. Drug Discov. 9, 387-398
30. Johnson, S. M., Connelly, S., Fearns, C., Powers, E. T., and Kelly, J. W. (2012) The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J. Mol. Biol. 421, 185-203
31. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (Pubitemid 34288846)
32. Sambashivan, S., Liu, Y., Sawaya, M. R., Gingery, M., and Eisenberg, D. (2005) Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437, 266-269 (Pubitemid 41294490)
33. Plakoutsi, G., Bemporad, F., Calamai, M., Taddei, N., Dobson, C. M., and Chiti, F. (2005) Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J. Mol. Biol. 351, 910-922 (Pubitemid 41111905)
34. Guo, Z., and Eisenberg, D. (2006) Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. Proc. Natl. Acad. Sci. U.S.A. 103, 8042-8047 (Pubitemid 43801049)
35. Yamasaki, M., Li, W., Johnson, D. J., and Huntington, J. A. (2008) Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 1255-1258
36. Stroud, J. C., Liu, C., Teng, P. K., and Eisenberg, D. (2012) Toxic fibrillar oligomers of amyloid-β have cross-β structure. Proc. Natl. Acad. Sci. U.S.A. 109, 7717-7722
37. Knaus, K. J., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W. K., and Yee, V. C. (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8, 770-774 (Pubitemid 32803594)
38. Olafsson, I., and Grubb, A. (2000) Hereditary cystatin C amyloid angiopathy. Amyloid 7, 70-79
39. Lin, H., Bhatia, R., and Lal, R. (2001) Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15, 2433-2444 (Pubitemid 33063171)
40. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., and Lal, R. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A. 102, 10427-10432 (Pubitemid 41061570)
41. Kagan, B. L. (2012) Membrane pores in the pathogenesis of neurodegenerative disease. Prog. Mol. Biol. Transl. Sci. 107, 295-325
42. Bjarnadottir, M., Nilsson, C., Lindstrom, V., Westman, A., Davidsson, P., Thormodsson, F., Blondal, H., Gudmundsson, G., and Grubb, A. (2001) The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid 8, 1-10 (Pubitemid 32210175)
43. Schrodinger, L. L. C. (2010) The PyMOL Molecular Graphics System, version 1.3r1, Schrödinger, LLC, New York
44. Janowski, R., Kozak, M., Abrahamson, M., Grubb, A., and Jaskolski, M. (2005) 3D domain-swapped human cystatin C with amyloid-like intermolecular β-sheets. Proteins 61, 570-578 (Pubitemid 41547413)